Uniplan Investment Counsel’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.16M Sell
2025
Q1
$7.23M Buy
2024
Q4
$7.3M Buy
2024
Q3
$5.32M Buy
2024
Q2
$4.18M Buy
2024
Q1
$3.01M Buy